Related Experiment Videos
Outcomes of lipid-lowering treatment in postmenopausal women
1State University of New York Health Science Center at Brooklyn, 11203, USA. jclarosa@downstate.edu
Insights
Lipid and lipoprotein levels impact coronary risk differently in women versus men, with triglycerides and HDL being key factors for women. Cholesterol-lowering therapies, including statins, offer similar benefits for both sexes.
Area of Science:
- Cardiology
- Endocrinology
- Lipidology
Background:
- Elevated triglycerides and low high-density lipoprotein (HDL) are significant coronary risk factors in women, unlike elevated low-density lipoprotein (LDL) which is less critical compared to men.
- Lipid and lipoprotein levels in women are influenced by diabetes mellitus, body weight distribution, and menopausal status.
Purpose of the Study:
- To examine the differential impact of lipid and lipoprotein levels on coronary risk in women compared to men.
- To highlight the role of diabetes as a potent risk predictor in women.
- To discuss the therapeutic strategies for managing lipoprotein disorders.
Main Methods:
- Review of clinical trial evidence on cholesterol lowering.
- Analysis of factors modifying lipids and lipoproteins in women.
- Evaluation of the efficacy and tolerability of statin therapy.
Main Results:
- Cholesterol-lowering interventions demonstrate virtually identical benefits in women and men.
- Diabetes mellitus is a more significant predictor of cardiovascular risk in women, potentially due to the impact of elevated triglycerides and lipoprotein glycosylation.
- Statin therapy is highly effective and well-tolerated for the majority of patients with lipoprotein disorders.
Conclusions:
- While lipid profiles present unique risk factors for women, such as triglycerides and HDL, the benefits of cholesterol-lowering therapies are consistent across sexes.
- Understanding the influence of factors like diabetes is crucial for risk assessment in women.
- Statins represent a primary, effective treatment for managing lipoprotein disorders in both women and men.
Abstract:
Elevated triglycerides and low high-density lipoprotein (HDL) levels are more important coronary risk factors in women, and elevated low-density lipoprotein (LDL) levels less important in women, than men. There is clear-cut evidence in clinical trials that the benefit of cholesterol lowering in women and men is virtually identical. Modifiers of lipids and lipoproteins in women include diabetes mellitus, bodyweight and its distribution, and menopausal status. Diabetes is a more powerful predictor of risk in women than men. This may relate to the importance of elevated triglycerides as a risk factor in women, and to the effects of lipoprotein glycosylation, which lead to increased susceptibility to arterial deposition of LDL and decreased reverse cholesterol transport with HDL. Therapy for lipoprotein disorders in women and men is identical. For the overwhelming majority of patients, treatment with statin therapy is both highly efficacious and well tolerated.